“…Estimates of gene dosage have typically been based on comparisons with a reference standard; absolute (i.e., molar) quantitation has been reported by the inclusion of known quantities of PCR competitor. Other approaches, including the study of junction fragments or microsatellite inheritance, and, more recently, long accurate PCR [CoulterMackie et al, 1998], fluorescent in situ hybridization (FISH) [Pemble et al, 1994;Brockmoller et al, 1992], comparative genomic hybridization (CGH) [Bentz et al, 1998;Kraus et al, 1997;Pinkel et al, 1998], and array-CGH [Pollack et al, 1999] have also been employed. In some cases, knowledge of the gene (or exon) dosage may not be sufficient to establish the pathogenic consequences of a genotype, as for example in spinal muscular atrophy, where gene duplications and unstable regions of the genome can complicate the issue [Parsons et al, 1998].…”